mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
As the fifth most common cancer in men and the eighth most common cancer in women, hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide, with standard chemotherapy and radiation being minimally effective in prolonging survival. Virus hepatitis, particularly HBV and...
Main Authors: | Zhuo Wang, Wei Jin, Hongchuan Jin, Xian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/735672 |
Similar Items
-
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
by: Gustavo Ferrín, et al.
Published: (2020-02-01) -
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
by: Mengnan Guo, et al.
Published: (2021-01-01) -
Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma
by: Xianqiong Liu, et al.
Published: (2019-07-01) -
mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01) -
CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
by: Xiu-Yan Huang, et al.
Published: (2019-05-01)